🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase II, randomized, double-blind, placebo-controlled study of the safety ...
Status
Completed
Location
National Taiwan University Hospital
Start Date
2018-10-15
Trial ID
NCT04133987
Treatments Being Tested
Randomized, observer-blinded, multicenter, dose-escalation Phase 1 clinical...
Status
Completed
Location
Optimal Research, LLC
Start Date
2018-03-05
Trial ID
NCT03382964
Treatments Being Tested
The purpose of this study is to evaluate the reactogenicity, safety and imm...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2019-10-25
Trial ID
NCT04006808
Treatments Being Tested
The study is aimed at assessing the safety and immunogenicity of HCV prime-...
Status
Completed
Location
Centre for Cinical Vaccinology and Tropical Medicine, Univeristy of Oxford
Start Date
2017-12-04
Trial ID
NCT03688061
Treatments Being Tested
This is a phase 1 study to assess the safety and immunogenicity of differen...
Status
Completed
Location
Josha Research
Start Date
2022-05-30
Trial ID
NCT05228314
The purpose of this study is to assess the safety and tolerability of an in...
Status
Completed
Location
Heartland Research Associates, LLC
Start Date
2017-11-29
Trial ID
NCT03303625
Treatments Being Tested
The main objective of this trial is to evaluate the safety and immunogenici...
Status
Recruiting
Location
Nucleus Network
Start Date
2026-03-17
Trial ID
NCT07478952
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity and the safety ...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-10-20
Trial ID
NCT00385840
Treatments Being Tested
The goal of this clinical trial is to evaluate the safety and reactogenicit...
Status
Unknown
Location
Velocity Clinical Research
Start Date
2023-10-16
Trial ID
NCT06002503